ReviewAmerican journal of cancer research2016
A perspective on anti-EGFR therapies targeting triple-negative breast cancer.
Katsuya Nakai et al.PubMed ↗Full text ↗
No numbers read from the abstract.
215 papers cite itlatest 60 shown
this papertrialcites it